7158 Gao et al.
Asian J. Chem.
7.60 (d, J = 8.0 Hz, 2H), 7.49-7.53 (m, 1H), 7.33-7.38 (m,
3H), 7.13-7.17 (m, 2H), 2.32 (s, 3H).
7.85 (m, 1H), 7.71 (d, J = 8.4 Hz, 2H), 7.51-7.56 (m, 1H),
7.34-7.38 (m, 1H), 7.17 (d, J = 8.0 Hz, 1H), 2.58 (s, 3H), 2.33
(s, 3H).
Compound 2 (C15H12O3NCl):White needle crystal; yield:
40 %; m.p. 133-134 °C; IR (KBr, νmax, cm-1): 3487, 3285, 3190,
3111, 3048, 1755, 1656, 1608, 1595, 1533, 1493, 1447, 1396,
Assay of antifungal activity: The antifungal activity of
the synthesized compounds against Sclerotinia sclerotiorum,
Helminthosprium maydis, Botrytis cinerea and Rhizoctonia
solani were determined using the plate growth rate method17.
The synthesized compounds and carbendazim (purity
90 %) were dissolved in dimethyl sulfoxide, respectively. The
two solutions were diluted into five different concentrations
with distilled water, respectively. They were added to the sterile
culture medium (PDA) at 45 °C, mixed to homogeneity and
transferred to sterile Petri dishes to solidify. A mycelium agar
disc (5 mm in diameter) of the target fungi was placed in the
center of PDA plates. They were incubated at 28 °C in the
dark until the target fungi used as controls covered the surface
of these plates. Control groups were treated with the corres-
ponding solutions without the synthesized compounds or
carbendazim. The experiment for each concentration was
replicated three times. The diameter of the fungi in the cultures
was measured and the inhibition of growth was calculated
according to the formula of Abbott.
1
1317, 1207, 1172, 830, 751, 701, 589; H NMR (400 MHz,
CDCl3) δ (ppm): 8.10 (s, 1H), 7.80 (d, J = 7.6 Hz, 1H), 7.49-
7.55 (m, 3H), 7.30-7.36 (m, 3H), 7.14 (d, J = 8.4 Hz, 1H),
2.31 (s, 3H).
Compound 3 (C15H12O3NBr): Light yellow needle crystal;
yield: 82 %; m.p. 138-139 °C; IR (KBr, νmax, cm-1): 3485, 3281,
3183, 3105, 3042, 1755, 1656, 1597, 1607, 1587, 1526, 1490,
1446, 1391, 1317, 1208, 1173, 826, 750, 700, 589; 1H NMR
(400 MHz, CDCl3) δ (ppm): 8.15 (s, 1H), 7.77 (d, J = 7.6 Hz,
1H), 7.42-7.52 (m, 5H), 7.32 (t, J = 7.6 Hz, 1H), 7.13 (d, J =
8.0 Hz, 1H), 2.30 (s, 3H).
Compound 4 (C15H12O5N2): Golden yellow crystal; yield:
54 %; m.p. 90-91 °C; IR (KBr, νmax, cm-1): 3315, 3123, 3068,
3030, 1775, 1675, 1604, 1585, 1501, 1451, 1370, 1298, 1176,
1146, 1121, 812, 744, 693, 592; 1H NMR (400 MHz, CDCl3)
δ (ppm): 11.10 (s, 1H), 8.91 (d, J = 8.4 Hz, 1H), 8.24 (d, J =
8.4 Hz, 1H), 7.95 (d, J = 7.6 Hz, 1H), 7.71 (t, J = 7.6 Hz, 1H),
7.58 (t, J = 7.6 Hz, 1H), 7.40 (t, J = 7.6 Hz, 1H), 7.21-7.26 (m,
2H), 2.36 (s, 3H).
RESULTS AND DISCUSSION
Compound 5 (C16H15O3N): Light yellow crystal; yield:
85 %; m.p. 139-140 °C; (KBr, νmax, cm-1): 3494, 3280, 3193,
3122, 3060, 2921, 1756, 1654, 1606, 1533, 1513, 1446, 1382,
All the synthesized derivatives of aspirin were screened
for their activity against Sclerotinia sclerotiorum, Helmintho-
sprium maydis, Botrytis cinerea and Rhizoctonia solani. The
results are presented in Table-1. Most of them were active
against the four different pathogenic fungi at a concentration
of 100 mg L-1. The inhibition rate of compounds 1 and 2 against
Helminthosprium maydis reached 92.5 and 91.6 %, respec-
tively, which was higher than carbendazim. The inhibition rate
of compound 3 against Botrytis cinerea reached 90.6 %, which
was close to carbendazim.
1
1220, 1206, 812, 762, 701; H NMR (400 MHz, CDCl3) δ
(ppm): 7.98 (s, 1H), 7.84 (d, J = 7.6 Hz, 1H), 7.47-7.53 (m,
3H), 7.35 (t, J = 7.4 Hz, 1H), 7.16 (t, J = 7.2 Hz, 3H), 2.34
(s, 3H), 2.32 (s, 3H).
Compound 6 (C16H15O4N): Light purple solid; yield:
77 %; m.p. 119-120 °C; IR (KBr, νmax, cm-1): 3341, 3246,
3123, 3044, 3009, 2937, 2839, 1760, 1643, 1608, 1599, 1513,
1445, 1371, 1301, 1219, 1198, 816, 759, 634; 1H NMR (400
MHz, CDCl3) δ (ppm): 7.94 (s, 1H), 7.83 (d, J = 8.0 Hz,
1H), 7.49-7.52 (m, 3H), 7.35 (t, J = 7.2 Hz, 1H), 7.15 (d, J =
8.0 Hz, 1H), 6.90 (d, J = 9.2 Hz, 2H), 3.81 (s, 3H), 2.33 (s,
3H).
A series of derivatives of aspirin have been successfully
synthesized and tested for their antifungal activity against
Sclerotinia sclerotiorum, Helminthosprium maydis, Botrytis
cinerea and Rhizoctonia solani. The preliminary results
suggested that the design and synthesis of these compounds
may be conducive to the antifungal activity of derivatives of
aspirin. They are also promising and beneficial to further
studies in developing new and more effective fungicides in
the agricultural chemistry field. However, there is more work
Compound 7 (C17H15O4N): Orange yellow crystal; yield:
35 %; m.p. 160-161 °C; (KBr, νmax, cm-1): 3502, 3330, 3184,
3104, 3000, 1772, 1682, 1601, 1586, 1522, 1447, 1366, 1314,
1
1218, 1196, 1180, 820, 759, 698, 595; H NMR (400 MHz,
CDCl3) δ (ppm): 8.37 (s, 1H), 7.97 (d, J = 8.8 Hz, 2H), 7.82-
TABLE-1
ANTIFUNGAL ACTIVITY OF COMPOUNDS 1-7 AGAINST Sclerotinia sclerotiorum,
Helminthosprium maydis, Botrytis cinerea AND Rhizoctonia solani AT 100 mg L–1
Inhibition of growth (%)∗
Compound
R
Sclerotinia sclerotiorum
Helminthosprium maydis
Botrytis cinerea
72.0
Rhizoctonia solani
1
H
4-Cl
87.5
93.7
87.7
50.6
91.1
91.1
71.7
100
92.5
91.6
72.7
67.8
78.5
70.4
79.4
87.5
88.7
63.8
61.3
67.7
48.9
46.2
37.1
100
2
88.8
3
4-Br
90.6
4
4-NO2
4-CH3
4-OCH3
4-COCH3
–
66.4
5
68.2
6
60.8
7
77.2
Carbendazim
91.3
∗Based on the mean of triplicates